Stockreport

Larimar Therapeutics to Participate in Upcoming Investor Conferences

Larimar Therapeutics, Inc.  (LRMR) 
PDF BALA CYNWYD, Pa., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing t [Read more]